Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
THE OPTIMUM USE OF INTRAVENOUS IMMUNOGLOBULIN FOR PROPHYLAXIS OF OPPORTUNISTIC INFECTION IN HIV-INFECTED ADULTS
Autore:
KIEHL MG; MULLER C;
Indirizzi:
DEPT HEMATOL ONCOL,BONE MARROW TRANSPLANTAT UNIT,DR OTTMAR KOHLER STR2 IDAR OBERSTEIN GERMANY UNIV MUNSTER,DEPT INTERNAL MED,HEMATOL ONCOL SECT D-4400 MUNSTER GERMANY
Titolo Testata:
Biodrugs
fascicolo: 4, volume: 10, anno: 1998,
pagine: 265 - 273
Fonte:
ISI
Lingua:
ENG
Soggetto:
HUMAN-IMMUNODEFICIENCY-VIRUS; AVIUM COMPLEX INFECTION; AIDS-RELATED COMPLEX; IMMUNE-DEFICIENCY-SYNDROME; B-CELL ACTIVATION; BACTERIAL-INFECTIONS; ANTIRETROVIRAL THERAPY; CONTROLLED TRIAL; RIFABUTIN PROPHYLAXIS; GAMMA-GLOBULIN;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
65
Recensione:
Indirizzi per estratti:
Citazione:
M.G. Kiehl e C. Muller, "THE OPTIMUM USE OF INTRAVENOUS IMMUNOGLOBULIN FOR PROPHYLAXIS OF OPPORTUNISTIC INFECTION IN HIV-INFECTED ADULTS", Biodrugs, 10(4), 1998, pp. 265-273

Abstract

Immunoglobulin therapy is well established in the treatment of HIV-infected children with frequent bacterial infections or recurrent severebacterial infections, and the beneficial effects are well demonstrated. Such clear recommendations regarding intravenous immunoglobulin (IVIG) therapy are currently not available for adults. Several studies have been performed in adults to determine the effects of IVIG therapy in different dosages on the frequency and severity of infections, as well as on survival. Although most studies suffer from problems in design and low patient numbers, some conclusions can be drawn. The therapy is well tolerated and does not seem to have adverse effects on patients' immune functions. Most studies demonstrate beneficial results of IVIG treatment, especially on frequency and severity of infections in patients with advanced HIV disease. However, overall survival is, if at all, only slightly prolonged. Despite the observed beneficial effects,it is unclear whether these benefits justify the high costs of continuous NTG therapy. The role of IVIG therapy could be further altered bythe recent improvements in antiviral drug therapy. Taken together, the available data suggest an individualised usage of IVIG as adjunctivetherapy in adults with advanced HIV infection and severe or recurrentbacterial infections.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/11/20 alle ore 10:37:28